Cargando…
COVID-19 in Chronic Myeloid Leukemia Patients - Brazilian Experience
[Image: see text] Coronavirus disease (COVID-19) is an infectious disease caused by the newly discovered coronavirus Sars-Cov2. In Brazil, the first COVID-19 case was diagnosed in February 2020, and since then, the number of cases and deaths has increased exponentially, reaching 2.610.102 confirmed...
Autores principales: | Pagnano, Katia B, Mourão Toreli, Ana Carolina, Perobelli, Leila Martins, Quixada, Acy TS, Seguro, Fernanda S, Bendit, Israel, Delamain, Marcia Torresan, Sapelli, Jaqueline, Moura, Muriel Silva, Bortolini, Jaisson, Lourenço, André LG, Gonçalves, Natália N, Conchon, Monika, Nucci, Fabio Moore, Oliveira, Luciene Da Cruz, Magalhães, Gustavo HR, Funke, Vaneuza, Tavares, Renato, Centrone, Renato Torrescasana, Santos, Fabio PS, Fogliatto, Laura, Palma, Leonardo Carvalho, Clementino, Nelma D, Hokama, Paula OM, Boquimpani, Carla M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330316/ http://dx.doi.org/10.1182/blood-2020-138563 |
Ejemplares similares
-
COVID-19 IN CHRONIC MYELOID LEUKEMIA PATIENTS – BRAZILIAN EXPERIENCE
por: Pagnano, KBB, et al.
Publicado: (2021) -
COVID-19 IN CHRONIC MYELOID LEUKEMIA PATIENTS – BRAZILIAN EXPERIENCE
por: Pagnano, K.B.B., et al.
Publicado: (2020) -
A Survey Conducted during COVID-19 Pandemic Among Brazilian Chronic Myeloid Leukemia and Philadelphia-Negative Myeloproliferative Neoplasms Patients
por: Fechio, Leonardo, et al.
Publicado: (2021) -
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice
por: Boquimpani, Carla, et al.
Publicado: (2022) -
IMPACTO DA PANDEMIA DO COVID-19 NA ROTINA DE DISTRIBUIÇÃO DE HEMOCOMPONENTES
por: Taguchi, E.M., et al.
Publicado: (2020)